Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 1486 AL 1500

Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)

Pajewski NM, Elahi FM, Tamura MK, Hinman JD, Nasrallah IM, Ix JH, Miller LM, Launer LJ, Wright CB, Supiano MA, Lerner AJ, Sudduth TL, Killeen AA, Cheung AK, Reboussin DM, Wilcock DM, Williamson JD.

Alzheimers Dement. 2022 Aug;18(8):1472-1483. doi: 10.1002/alz.12496. Epub 2021 Nov 17.

Current progress in aptamer-based sensing tools for ultra-low level monitoring of Alzheimer's disease biomarkers

Zamanian J, Khoshbin Z, Abnous K, Taghdisi SM, Hosseinzadeh H, Danesh NM.

Biosens Bioelectron. 2022 Feb 1;197:113789. doi: 10.1016/j.bios.2021.113789. Epub 2021 Nov 14.

Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis

Anita NZ, Zebarth J, Chan B, Wu CY, Syed T, Shahrul D, Nguyen MM, Pakosh M, Herrmann N, Lanctôt KL, Swardfager W.

Brain Behav Immun. 2022 Feb;100:55-69. doi: 10.1016/j.bbi.2021.11.005. Epub 2021 Nov 20.

A potential biomarker of preclinical Alzheimer's disease: The olfactory dysfunction and its pathogenesis-based neural circuitry impairments

Yan Y, Aierken A, Wang C, Song D, Ni J, Wang Z, Quan Z, Qing H.

Neurosci Biobehav Rev. 2022 Jan;132:857-869. doi: 10.1016/j.neubiorev.2021.11.009. Epub 2021 Nov 20.

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M.

Lancet Neurol. 2022 Jan;21(1):66-77. doi: 10.1016/S1474-4422(21)00361-6. Epub 2021 Nov 24.

[Depression and its relationship with mild cognitive impairment and Alzheimer disease: A review study]

González Hernández A, Rodríguez Quintero AM, Bonilla Santos J.

Rev Esp Geriatr Gerontol. 2022 Mar-Apr;57(2):118-128. doi: 10.1016/j.regg.2021.10.002. Epub 2021 Nov 27.

Blood-based biomarkers for Alzheimer's disease

Leuzy A, Mattsson-Carlgren N, Palmqvist S, Janelidze S, Dage JL, Hansson O.

EMBO Mol Med. 2022 Jan 11;14(1):e14408. doi: 10.15252/emmm.202114408. Epub 2021 Dec 3.

Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects

Tumati S, Herrmann N, Marotta G, Li A, Lanctôt KL.

Neurochem Int. 2022 Jan;152:105250. doi: 10.1016/j.neuint.2021.105250. Epub 2021 Dec 2.

Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence

Gleason CE, Zuelsdorff M, Gooding DC, Kind AJH, Johnson AL, James TT, Lambrou NH, Wyman MF, Ketchum FB, Gee A, Johnson SC, Bendlin BB, Zetterberg H.

Alzheimers Dement. 2022 Aug;18(8):1545-1564. doi: 10.1002/alz.12511. Epub 2021 Dec 6.

The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment

Stites SD, Gill J, Largent EA, Harkins K, Sankar P, Krieger A, Karlawish J.

Soc Sci Med. 2022 Jan;292:114620. doi: 10.1016/j.socscimed.2021.114620. Epub 2021 Dec 1.

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X.

Ageing Res Rev. 2022 Feb;74:101544. doi: 10.1016/j.arr.2021.101544. Epub 2021 Dec 18.

Association of CSF Aβ(38) Levels With Risk of Alzheimer Disease-Related Decline

Cullen N, Janelidze S, Palmqvist S, Stomrud E, Mattsson-Carlgren N, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.

Neurology. 2022 Mar 1;98(9):e958-e967. doi: 10.1212/WNL.0000000000013228. Epub 2021 Dec 22.

The Impact of Systemic Inflammation on Alzheimer's Disease Pathology

Xie J, Van Hoecke L, Vandenbroucke RE.

Front Immunol. 2022 Jan 6;12:796867. doi: 10.3389/fimmu.2021.796867. eCollection 2021.

Diabetes and cognitive decline

Bellia C, Lombardo M, Meloni M, Della-Morte D, Bellia A, Lauro D.

Adv Clin Chem. 2022;108:37-71. doi: 10.1016/bs.acc.2021.07.006. Epub 2021 Aug 23.

Roles of Gut Microbiota in Pathogenesis of Alzheimer's Disease and Therapeutic Effects of Chinese Medicine

Sun YX, Jiang XJ, Lu B, Gao Q, Chen YF, Wu DB, Zeng WY, Yang L, Li HH, Yu B.

Chin J Integr Med. 2022 Nov;28(11):1048-1056. doi: 10.1007/s11655-020-3274-5. Epub 2020 Sep 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias